International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 183 | Views: 266

Research Paper | Pharmaceutical Science | India | Volume 7 Issue 10, October 2018


Synthesis, Spectral Studies and Biological Evaluation of Hydrazone Derivative as Antimicrobial and Anticancer Agents

Diksha Saini | Monika Gupta [3]


Abstract: Hydrazone is a class of organic compounds formed by the fusion of carbonyl compounds with hydrazine. In the last few decades, the hydrazones have emerged as biologically important pharmacophores. The present work deals with the synthesis and evaluation of a new series of (2, 4-Dinitrophenyl) hydrazone derivatives as the hydrazones were synthesized by the reaction of various ketones with substituted hydrazine. The antimicrobial activity of the synthesized derivatives was carried out against Gram-negative bacteria Escherichia coli (MTCC 40) and Gram-positive bacteria Bacillus subtilis (MTCC 441) and Staphylococcus aureus (MTCC 87) by using Cup-plate agar diffusion method. Ciprofloxacin was used as standard drug for antibacterial activity. Six compounds 3a, 3d, 3e, 3f, 3g and 3j possessed good to moderate anti microbial activity. Compound 3f and 3g exhibited good antimicrobial activity against all the strains. The derivatives 3a-3j were further screened for anticancer activity against MCF-7 cell line using Adriamycin as standard. Seven compound 3a, 3d, 3e, 3f, 3g, 3i, 3j possessed good to moderate anticancer activity. Compound 3f exhibited best results in both assay. The structures of the synthesized compounds were established by IR and NMR spectral studies.


Keywords: Hydrazones, 2, 4-Dinitrophenyl hydrazones, cytotoxicity, Anti proliferative, Antimicrobial activity


Edition: Volume 7 Issue 10, October 2018,


Pages: 131 - 137


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top